Please use this identifier to cite or link to this item:
https://observatorio.fm.usp.br/handle/OPI/28598
| Title: | Updated Analyses of the International, Open-Label, Randomized, Phase 3 Alcanza Study: Longer-Term Evidence for Superiority of Brentuximab Vedotin Versus Methotrexate or Bexarotene for CD30-Positive Cutaneous T-Cell Lymphoma (CTCL) |
| Authors: | HORWITZ, Steven M.; SCARISBRICK, Julia J.; DUMMER, Reinhard; DUVIC, Madeleine; KIM, Youn H.; WALEWSKI, Jan; WHITTAKER, Sean; QUAGLINO, Pietro; ZINZANI, Pier Luigi; WOLTER, Pascal; ERADAT, Herbert; SANCHES, Jose A.; ORTIZ-ROMERO, Pablo L.; AKILOV, Oleg E.; TROTMAN, Judith; TAYLOR, Kerry; DALLE, Stephane; WEICHENTHAL, Michael; FISHER, David C.; STADLER, Rudolf; FELDMAN, Tatyana A.; KUZEL, Timothy M.; GRU, Alejandro A.; WANG, Yinghui; PALANCA-WESSELS, Maria Corinna; LIN, Hui-Min; LIU, Yi; LITTLE, Meredith; PRINCE, H. Miles |
| Citation: | BLOOD, v.130, suppl.1, 2017 |
| Appears in Collections: | Comunicações em Eventos - FM/MDT
Departamento de Dermatologia - FM/MDT Comunicações em Eventos - HC/ICHC
Instituto Central - HC/ICHC Comunicações em Eventos - LIM/53
LIM/53 - Laboratório de Micologia |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.